Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
121-135 of 2959 results
New England Biolabs launches Luna Universal qPCR & RT-qPCR kits
New England Biolabs (NEB) has launched its Luna Universal qPCR & RT-qPCR kits, which demonstrated better performance for DNA & RNA quantitation.
Diagnostics > In Vitro Diagnostics > News
Exosome Diagnostics launches first instrument for point of care liquid biopsy
Exosome Diagnostics announced that it has developed the first instrument for exosomal protein (exoProtein) capture and analysis directly from any biofluid.
Diagnostics > In Vitro Diagnostics > News
Abbott files suit to terminate $5.8bn acquisition of diagnostics firm Alere
By MDBR Staff Writer
Healthcare firm Abbott has lodged a complaint to terminate the $5.8bn deal to acquire diagnostics device and services provider Alere.
Diagnostics > In Vitro Diagnostics > News
NantHealth signs exclusive reseller agreement with Oncotest-Teva for GPS Cancer test in Israel
NantHealth has entered into an exclusive reseller agreement with Oncotest-Teva for GPS Cancer molecular test in Israel.
Diagnostics > In Vitro Diagnostics > News
Good Start Genetics signs marketing agreement with Roche Diagnostics for carrier screening in US
By MDBR Staff Writer
Good Start Genetics has announced that it has entered into a collaborative agreement with global healthcare leader Roche to sell Good Start's carrier screening service for inherited genetic disorders.
Diagnostics > In Vitro Diagnostics > News
Evogen, UCB partner to advance development of new proteomics-based blood test
By MDBR Staff Writer
Diagnostics firm Evogen has partnered with biopharmaceutical firm UCB to advance the development of its EvoScore START for improved diagnosis of epilepsy.
Diagnostics > In Vitro Diagnostics > News
SystemOne, Daktari collaborate to improve value of diagnostics
By MDBR Staff Writer
SystemOne and Daktari Diagnostics have partnered to bring connected diagnostics to developing world.
Diagnostics > In Vitro Diagnostics > News
MDNA selects Phi Life Sciences as US distribution partner for new liquid biopsy test
MDNA Life Sciences, the molecular diagnostics company pioneering the development of liquid biopsy tests based on the mitochondrial genome, announced that it has entered into a license agreement with Phi Life Sciences (Phi).
Diagnostics > In Vitro Diagnostics > News
ArcherDX introduces new immune repertoire sequencing assays
By MDBR Staff Writer
ArcherDX has expanded its assay product portfolio with the introduction of new immune repertoire sequencing assays.
Diagnostics > In Vitro Diagnostics > News
biosurfit gets CE mark for spinit HbA1c blood test
By MDBR Staff Writer
In vitro point-of-care (PoC) diagnostics firm biosurfit has secured CE mark for its spinit Haemoglobin A1c (HbA1c) test.
Diagnostics > In Vitro Diagnostics > News
Beckman Coulter introduces two automated systems in UK for microbiology diagnostics
By MDBR Staff Writer
Biomedical laboratory instruments maker Beckman Coulter has introduced two automated systems in the UK for microbiology diagnostics to help manage increasing pressure on the NHS.
Diagnostics > In Vitro Diagnostics > News
Abbott gets CE mark for new handheld blood testing platform
By MDBR Staff Writer
Healthcare firm Abbott has secured CE mark approval for its new handheld blood testing platform, i-STAT Alinity System.
Diagnostics > In Vitro Diagnostics > News
Akers Biosciences completes clinical trial for rapid diabetic ketoacidosis breath test
Akers Biosciences has completed a clinical trial for BreathScan DKA, the first single-use, non-invasive breath test to rapidly screen for diabetic ketoacidosis, a potentially life-threatening complication of diabetes caused by a lack of insulin in the body.
Diagnostics > In Vitro Diagnostics > News
Quidel gets FDA 510(k) clearance for new Solana molecular assay
By MDBR Staff Writer
Diagnostic testing solutions provider Quidel has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its Solana HSV-1+2/VZV assay for the detection of herpes simplex virus 1+2 and varicella zoster virus.
Diagnostics > In Vitro Diagnostics > News
Navidea signs asset purchase agreement with Cardinal Health
Navidea Biopharmaceuticals announced that it has entered into a definitive asset purchase agreement with Cardinal Health.
Diagnostics > In Vitro Diagnostics > News
121-135 of 2959 results